Diligence memo · auto-generated · as of July 2, 2026
Predictus BioSciences, Inc.
Predictus BioSciences, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Predictus BioSciences, Inc. operates in Biotechnology, based in WEST ROXBURY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Predictus BioSciences, Inc. has raised $500K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $500K on 2010-12-31.
Most recent recorded round closed around 2010-12-31.
Valuation (modeled)modeled
Provath models Predictus BioSciences, Inc. at approximately $28M (range $267K–$313M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.41× the median modeled value of Pre-Seed Biotechnology companies in 2010–2012 (132 peers) — value vs value, same stage and era. Within the normal band (141% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 15.5 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 11% of Biotechnology peers (4293 compared).
Modeled value ranks above 34% of those peers.
Closest niche peers: Hygeia Therapeutics, Inc., Act Biotech Inc, Ikonopedia, LLC, Iquum Inc, Koronis Pharma, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.